CBOE Makes Minority Investment in Eris Exchange, Announces Partnership

CBOE and Eris will develop product solutions aimed at Basell III and other swaps regulations.

Deals news

CBOE will join Eris' board of directors as part of the deal, financial terms of which were not disclosed. The two firms are also entering into a partnership to develop product solutions geared toward international regulatory reforms.

Basel III, European swap clearing and trading mandates and margin for un-cleared swaps were examples given in the release of potential areas of focus. The partnership will also lead to the development of new proprietary products and indexes across asset classes and increased distribution of Eris interest-rate swap futures and related market data.

"Our partnership with Eris demonstrates CBOE's ongoing focus on leveraging our product innovation expertise to capitalize on the continuing convergence of the over-the-counter (OTC) and listed marketplaces," said Edward Tilly, CEO of CBOE Holdings, in a statement. "Our partnership with Eris, like our partnership in CurveGlobal, positions CBOE to tap into that opportunity by bringing new capital efficiencies and exchange-traded products to the interest rate marketplace."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

FCA declines to directly regulate market data prices

A year-long investigation by the UK regulator to determine whether competition is hindered in the wholesale data markets has concluded with its decision not to directly regulate much-maligned data pricing and licensing structures.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here